Kim YC - Search Results

1

Park S, Choi CM, Hwang SS, Choi YL, Kim HY, Kim YC, Kim YT, Lee HY, Song SY, Ahn MJ. Park S, et al. Among authors: kim hy, kim yc, kim yt. J Thorac Oncol. 2021 Dec;16(12):1988-1993. doi: 10.1016/j.jtho.2021.09.007. J Thorac Oncol. 2021. PMID: 34809802 Free article. No abstract available.

2

Predictors of the response to gefitinib in refractory non-small cell lung cancer.

Kim KS, Jeong JY, Kim YC, Na KJ, Kim YH, Ahn SJ, Baek SM, Park CS, Park CM, Kim YI, Lim SC, Park KO. Kim KS, et al. Among authors: kim yh, kim yi, kim yc. Clin Cancer Res. 2005 Mar 15;11(6):2244-51. doi: 10.1158/1078-0432.CCR-04-2081. Clin Cancer Res. 2005. PMID: 15788673

3

Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.

Wang LH, Kim SH, Lee JH, Choi YL, Kim YC, Park TS, Hong YC, Wu CF, Shin YK. Wang LH, et al. Among authors: kim sh, kim yc. Clin Cancer Res. 2007 Jan 1;13(1):102-10. doi: 10.1158/1078-0432.CCR-06-1467. Clin Cancer Res. 2007. PMID: 17200344

4

Surgically resected isolated hepatic metastasis from non-small cell lung cancer: a case report.

Kim KS, Na KJ, Kim YH, Ahn SJ, Bom HS, Cho CK, Kim HJ, Kim YI, Lim SC, Kim SO, Oh IJ, Song SY, Choi C, Kim YC. Kim KS, et al. Among authors: kim yh, kim yi, kim hj, kim yc, kim so. J Thorac Oncol. 2006 Jun;1(5):494-6. J Thorac Oncol. 2006. PMID: 17409905 Free article.

5

Clinical significance of CD99 down-regulation in gastric adenocarcinoma.

Lee JH, Kim SH, Wang LH, Choi YL, Kim YC, Kim JH, Park TS, Hong YC, Shin YK. Lee JH, et al. Among authors: kim sh, kim yc, kim jh. Clin Cancer Res. 2007 May 1;13(9):2584-91. doi: 10.1158/1078-0432.CCR-06-1785. Clin Cancer Res. 2007. PMID: 17473187

6

Efficacy of gemcitabine in patients with non-small cell lung cancer according to promoter polymorphisms of the ribonucleotide reductase M1 gene.

Kim SO, Jeong JY, Kim MR, Cho HJ, Ju JY, Kwon YS, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC. Kim SO, et al. Among authors: kim yi, kim mr, kim ks, kim yc. Clin Cancer Res. 2008 May 15;14(10):3083-8. doi: 10.1158/1078-0432.CCR-07-4591. Clin Cancer Res. 2008. PMID: 18483375

7

Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study.

In KH, Kwon YS, Oh IJ, Kim KS, Jung MH, Lee KH, Kim SY, Ryu JS, Lee SY, Jeong ET, Lee SY, Yum HK, Lee CG, Kim WS, Zo JI, Kim H, Kim YW, Kim SK, Lee JC, Kim YC. In KH, et al. Among authors: kim h, kim sy, kim ks, kim sk, kim yc, kim ws, kim yw. Lung Cancer. 2009 May;64(2):232-7. doi: 10.1016/j.lungcan.2008.08.005. Epub 2008 Sep 21. Lung Cancer. 2009. PMID: 18809225

8

p53 codon 72 polymorphism and the risk of lung cancer in a Korean population.

Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yun WJ, Kim YC, Oh IJ, Kim KS, Shin MH. Piao JM, et al. Among authors: kim hn, kim ks, kim yc. Lung Cancer. 2011 Sep;73(3):264-7. doi: 10.1016/j.lungcan.2010.12.017. Epub 2011 Feb 11. Lung Cancer. 2011. PMID: 21316118

9

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, Pedersen JH, Swanson SJ, Travis WD, Wisbuba II, Noguchi M, Mulshine JL; IASLC CT Screening Workshop 2011 Participants. Field JK, et al. J Thorac Oncol. 2012 Jan;7(1):10-9. doi: 10.1097/JTO.0b013e31823c58ab. J Thorac Oncol. 2012. PMID: 22173661 Free article.

10

Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: a single-arm, open-label, phase II study.

Oh IJ, Ban HJ, Kim KS, Kim YC. Oh IJ, et al. Among authors: kim ks, kim yc. Lung Cancer. 2012 Jul;77(1):121-7. doi: 10.1016/j.lungcan.2012.01.012. Epub 2012 Feb 12. Lung Cancer. 2012. PMID: 22333554 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,218 results

Search Page